Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs.
Pierre DecazesSamy AmmariAntoine De PréviaLéo MottayLittisha LawranceYounes BelkouchiBaya BenatsouLaurence AlbigesCorinne BalleyguierPierre VeraNathalie LassauPublished in: Diagnostics (Basel, Switzerland) (2023)
automatic and 3D body composition on pre-therapeutic CT is feasible and can improve prognostication in patients treated with anti-angiogenic drugs. Moreover, the 3D measurements appear to be more effective than their 2D counterparts.